Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Addiction. 2009 Jun 22;104(9):1588–1596. doi: 10.1111/j.1360-0443.2009.02624.x

Table 1.

Baseline and Demographic Characteristics by Treatment Condition

Placebo Gum
(n = 51)
Active Gum
(n = 45)
Age (M, SD) 44.8 (10.1) 45.1 (10.2)
Women (%) 29.4 28.9
Race (%)
 White 88.2 91.1
 Black 3.9 6.7
 Hispanic 3.9 2.2
 Other (bi-racial) 3.9 0.0
Education (% college degree)* 25.5 51.1
Baseline cigarettes/day (M, SD) 25.0 (10.3) 26.0 (9.16)
Carbon monoxide ppm (M, SD) 29.7 (13.6) 29.7 (13.4)
FTND (M, SD)* 5.45 (2.17) 6.47 (2.33)
90-Day baseline alcohol PDA (M, SD) 0.28 (0.26) 0.28 (0.27)
90-Day baseline alcohol PDH (M, SD) 0.58 (0.32) 0.56 (0.31)
90-day baseline other drug use (% any use)
 Cocaine 13.7 13.3
 Cannabis 19.6 26.6
CES-D (M, SD)* 15.5 (5.61) 19.4 (8.67)
Veteran (%) 29.4 33.3

Note. FTND = Fagerstrom Test for Nicotine Dependence, PDA = Percent Days Abstinent, PDH = Percent Days Heavy, CES-D = Center for Epidemiologic Studies Depression Scale.

*

p < .05.